Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.550
-0.020 (-1.27%)
Dec 5, 2025, 4:00 PM EST - Market closed
Autolus Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 413 | 625 | 1,120 | 329 | 378 | 468 | |
| Market Cap Growth | -48.16% | -44.17% | 240.67% | -13.12% | -19.06% | -21.26% | |
| Enterprise Value | 370 | 269 | 1,057 | 233 | 227 | 343 | |
| Last Close Price | 1.55 | 2.35 | 6.44 | 1.90 | 5.19 | 8.94 | |
| PS Ratio | 8.07 | 61.80 | 659.69 | 51.70 | 162.43 | 272.63 | |
| PB Ratio | 1.55 | 1.46 | 10.05 | 1.10 | 1.21 | 2.23 | |
| P/TBV Ratio | 1.68 | 1.51 | 10.05 | 1.10 | 1.21 | 2.23 | |
| EV/Sales Ratio | 7.24 | 26.63 | 622.48 | 36.69 | 97.51 | 199.84 | |
| Debt / Equity Ratio | 1.23 | 0.70 | 2.01 | 0.50 | 0.22 | 0.26 | |
| Asset Turnover | 0.07 | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Quick Ratio | 5.52 | 10.48 | 5.90 | 8.87 | 11.79 | 5.44 | |
| Current Ratio | 6.19 | 10.88 | 6.15 | 9.18 | 12.15 | 5.86 | |
| Return on Equity (ROE) | -60.56% | -81.91% | -101.61% | -48.64% | -54.30% | -61.13% | |
| Return on Assets (ROA) | -22.99% | -25.99% | -25.35% | -19.94% | -25.07% | -35.16% | |
| Return on Capital (ROIC) | -25.02% | -28.40% | -27.98% | -21.52% | -27.18% | -38.55% | |
| Return on Capital Employed (ROCE) | -47.30% | -33.40% | -53.10% | -32.20% | -37.20% | -64.50% | |
| Earnings Yield | -54.49% | -35.28% | -18.60% | -45.27% | -37.55% | -30.39% | |
| FCF Yield | -69.14% | -36.51% | -13.98% | -37.45% | -33.48% | -28.33% | |
| Buyback Yield / Dilution | -14.65% | -46.69% | -83.11% | -31.78% | -39.81% | -19.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.